Search results for “CD37” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 507 patents, we discovered top 35 key players by total patent application. Boehringer Ingelheim International GmbH, Emergent Product Development Seattle, Nordic Nanovector ASA are dominant in this area. They take 39.84% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 92
Emergent Product Development Seattle
Washington, United States
Patent: 66
Nordic Nanovector ASA
Oslo, Norway
Patent: 44
ImmunoGen, Inc.
Massachusetts, United States
Patent: 37
Genmab Holding BV
Utrecht, Netherlands
Patent: 26
Biogen, Inc.
Massachusetts, United States
Patent: 22
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 20
Agensys, Inc.
California, United States
Patent: 20
Aptevo Research And Development Llc
Washington, United States
Patent: 16
The General Hospital Corp.
Massachusetts, United States
Patent: 15
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 11 patents, we discovered top 3 start-ups by total patent application.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
STARTUP
Evox Therapeutics Ltd.
United Kingdom
Patent: 1
STARTUP
Mursla Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 116 patents applied in the last 5 years. We discover 19 most active companies in this area. The fast-growing Genmab Holding BV, Chugai Pharmaceutical Co., Ltd., The General Hospital Corp. take 52.59% of patent filing during this period.
Genmab Holding BV
Utrecht, Netherlands
Patent: 26
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 20
The General Hospital Corp.
Massachusetts, United States
Patent: 15
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Forevertek Biotechnology Co Ltd
United States
Patent: 3
Promab Biotechnologies, Inc.
California, United States
Patent: 3
Heidelberg Pharma Research GmbH
Germany
Patent: 2
Agensys, Inc.
California, United States
Patent: 2
Hunan ProMab Biotechnologies Co. Ltd.
Hunan Sheng, China
Patent: 2
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 116 patents in last 5 years, we discover 15 new entrants. Genmab Holding BV, Chugai Pharmaceutical Co., Ltd., The General Hospital Corp. are the most active new entrants in this area.
Genmab Holding BV
Utrecht, Netherlands
Patent: 26
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 20
The General Hospital Corp.
Massachusetts, United States
Patent: 15
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 9
Forevertek Biotechnology Co Ltd
United States
Patent: 3
Promab Biotechnologies, Inc.
California, United States
Patent: 3
Heidelberg Pharma Research GmbH
Germany
Patent: 2
Hunan ProMab Biotechnologies Co. Ltd.
Hunan Sheng, China
Patent: 2
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Nagoya University
Aichi-ken, Japan
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 15 patents, we discovered top 3 universities and scientific research institutions by total patent application.
National University of Singapore
Central Region, Singapore
Patent: 1
Nagoya University
Aichi-ken, Japan
Patent: 1
Tokai National Higher Education & Research System
Aichi-ken, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: